Mohamed Genead
Directeur Général chez Aviceda Therapeutics, Inc.
Postes actifs de Mohamed Genead
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| Fondateur | - | - | |
| President | - | - | |
| Secrétaire Général | - | - | |
| Treasurer | - | - | |
Aviceda Ophthalmics, Inc.
 Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Directeur Général | - | - |
| Président | - | - | |
| Directeur Financier/CFO | - | - | |
| President | - | - | |
| Secrétaire Général | - | - |
Historique de carrière de Mohamed Genead
Anciens postes connus de Mohamed Genead
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Directeur Technique/Scientifique/R&D | 01/05/2017 | 01/11/2017 |
| University of Illinois | Corporate Officer/Principal | - | - |
| OCUGEN, INC. | Directeur Technique/Scientifique/R&D | - | - |
Statistiques
Internationale
| Etats-Unis | 5 |
| France | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectorielle
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Bourse
- Insiders
- Mohamed Genead
- Expérience
